科研之友
微信
新浪微博
Facebook
分享链接
摘要
One of the main challenges associated with diagnosis of Alzheimer disease (AD) is the identification and validation of blood-based biomarkers. Three recent studies describe different approaches to blood-based biomarker research in AD, and provide hope for a simple, minimally invasive means of diagnosis. Laske, C. Nat. Rev. Neurol. 8, 541-542 (2012); published online 14 August 2012; doi:10.1038/nrneurol.2012.173
- 出版日期2012-10
